Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.58 AUD -3.33%
Market Cap: AU$127.1m

Somnomed Ltd
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Somnomed Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Somnomed Ltd
ASX:SOM
Total Current Assets
AU$43.8m
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
10%
C
Cyclopharm Ltd
ASX:CYC
Total Current Assets
AU$28.5m
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
8%
Cochlear Ltd
ASX:COH
Total Current Assets
AU$1.4B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
10%
Optiscan Imaging Ltd
ASX:OIL
Total Current Assets
AU$23.2m
CAGR 3-Years
60%
CAGR 5-Years
16%
CAGR 10-Years
32%
Austco Healthcare Ltd
ASX:AHC
Total Current Assets
AU$47.5m
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Total Current Assets
AU$23.5m
CAGR 3-Years
34%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Somnomed Ltd
Glance View

Market Cap
127.1m AUD
Industry
Health Care

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

SOM Intrinsic Value
0.59 AUD
Undervaluation 2%
Intrinsic Value
Price AU$0.58

See Also

What is Somnomed Ltd's Total Current Assets?
Total Current Assets
43.8m AUD

Based on the financial report for Dec 31, 2025, Somnomed Ltd's Total Current Assets amounts to 43.8m AUD.

What is Somnomed Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
10%

Over the last year, the Total Current Assets growth was 5%. The average annual Total Current Assets growth rates for Somnomed Ltd have been 10% over the past three years , 3% over the past five years , and 10% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett